title: Characterization and large production of human monoclonal antibodies against the HIV-1 envelope.
abstract: Peripheral blood lymphocytes from a volunteer immunized with a recombinant vaccinia virus VSC-25 expressing the gp160 env protein of HTLV-IIIB strain and from an asymptomatic HIV-infected individual were immortalized by Epstein-Barr (EBV). Clones which secrete human monoclonal antibodies from the two individuals (DZ, IgG1, lambda and C31, IgG1, kappa) were obtained and were stable for more than 2 years. The two monoclonals were directed against the gp160 env protein of HIV, DZ directed against the gp41 and C31 directed against the gp120. C31 was group-specific, whereas DZ was directed against the HTLV-IIIB and HTLV-RF strains. The epitope recognized by DZ was mapped to the carboxy terminus of the gp41, by expression of HIV DNA fragments in a yeast system and peptide analysis. The C31 epitope was not expressed by the yeast library and not present among the peptides which were tested. Monoclonal antibodies had no inhibitory effect in an HIV-induced cell fusion assay, but DZ showed a weak neutralizing activity against the HTLV-IIIB strain. Cloned EBV-transformed cell lines were fused to a murine myeloma, which allowed the heteromyeloma to be cultivated in serum-free medium. The monoclonal antibodies were produced in large quantity in a hollow-fibre reactor at defined culture conditions and purification procedures.
authors.affiliation: INSERM U271, Lyon, France.
authors.forename: V
authors.initials: V
authors.lastname: Boyer
authors.forename: H
authors.initials: H
authors.lastname: Broly
authors.forename: S
authors.initials: S
authors.lastname: Souche
authors.forename: P
authors.initials: P
authors.lastname: Madaule
authors.forename: J
authors.initials: J
authors.lastname: Rossier
authors.forename: D
authors.initials: D
authors.lastname: Zagury
authors.forename: C
authors.initials: C
authors.lastname: Desgranges
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis* / Q000276:immunology / Q000302:isolation & purification / Q000633:toxicity; D000918:Antibody Specificity; D000939:Epitopes / Q000276:immunology; D005260:Female; D015686:Gene Products, env / Q000276:immunology; D015483:HIV Antibodies / Q000096:biosynthesis* / Q000276:immunology / Q000302:isolation & purification / Q000633:toxicity; D019302:HIV Envelope Protein gp160; D015497:HIV-1 / Q000276:immunology*; D006825:Hybridomas; D051379:Mice; D009500:Neutralization Tests; D011498:Protein Precursors / Q000276:immunology; D011817:Rabbits; D014759:Viral Envelope Proteins / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000939:Epitopes; D015686:Gene Products, env; D015483:HIV Antibodies; D019302:HIV Envelope Protein gp160; D011498:Protein Precursors; D014759:Viral Envelope Proteins